Coronavirus delays Biogen's Spinraza for some patients
Coronavirus delays Biogen's Spinraza for some patients
U.S. drugmaker Biogen Inc said on Wednesday that some patients on its drug Spinraza - which treats a rare disorder called spinal muscular atrophy (SMA) - are having their treatments postponed to prioritize COVID-19 patients.
from Reuters: Health https://ift.tt/2WpDZPT
via Blogger https://ift.tt/2QrA8Oq
March 19, 2020 at 05:57AM
U.S. drugmaker Biogen Inc said on Wednesday that some patients on its drug Spinraza - which treats a rare disorder called spinal muscular atrophy (SMA) - are having their treatments postponed to prioritize COVID-19 patients.
from Reuters: Health https://ift.tt/2WpDZPT
via Blogger https://ift.tt/2QrA8Oq
March 19, 2020 at 05:57AM
No comments